A Phase 1/2a study of Oral TSR-011 in Solid Tumors and Lymphomas

• Research type

  Research Study

• Full title

  A Phase 1/2a, Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients with Advanced Solid Tumors and Lymphomas

• IRAS ID

  129962

• Contact name

  Hendrik-Tobias Arkenau

• Contact email

  tobias.arkenau@sarahcannonresearch.co.uk

• Sponsor organisation

  TESARO

• Eudract number

  2013-000686-37

• ISRCTN Number

  ISRCTN

• REC name

  London - Central Research Ethics Committee

• REC reference

  13/LO/0986

• Date of REC Opinion

  11 Sep 2013

• REC opinion

  Further Information Favourable Opinion